Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125270261 | 12527026 | 1 | I | 201605 | 20160622 | 20160705 | 20160705 | EXP | US-GLAXOSMITHKLINE-US2016089401 | GLAXOSMITHKLINE | 53.75 | YR | F | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125270261 | 12527026 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 PUFF(S), BID | 6ZP3558 | 21254 | 2 | DF | BID | ||||||
| 125270261 | 12527026 | 2 | C | BACLOFEN. | BACLOFEN | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 3 | C | DUO NEBULIZER | 2 | 0 | |||||||||||||
| 125270261 | 12527026 | 4 | C | LANTUS | INSULIN GLARGINE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 5 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 6 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 8 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 9 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 10 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 11 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 12 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 13 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 14 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 15 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 16 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 17 | C | THEOPHYLLINE | THEOPHYLLINE ANHYDROUS | 1 | 0 | ||||||||||||
| 125270261 | 12527026 | 18 | C | TOPIRAMATE. | TOPIRAMATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125270261 | 12527026 | 1 | Chronic obstructive pulmonary disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125270261 | 12527026 | Drug ineffective | |
| 125270261 | 12527026 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125270261 | 12527026 | 1 | 2014 | 201606 | 0 |